1. Introduction

According to the company, the grant has been provided by the Biotechnology Industry Research Assistance Council (BIRAC) under the Department of Biotechnology (DBT). The proposed facility will have a capacity of around 100 tonnes per annum and will be established at BCML’s integrated manufacturing complex at Kumbhi in Uttar Pradesh.

The project is significant because PLA is a bio-based polymer that can be developed from renewable feedstocks and has applications in areas such as packaging and other material products. The facility is expected to help develop specialised PLA grades and co-polymers and generate the process knowledge required to take these products from research to commercial production.

2. Origin and Intent

The project is linked to the BioE3 Policy, which was approved by the Union Cabinet in 2024 to promote high-performance biomanufacturing in India. The policy seeks to strengthen research, entrepreneurship and the commercialisation of bio-based products while supporting sustainable and circular manufacturing practices.

One of the key areas identified under BioE3 is bio-based chemicals, biopolymers and enzymes. The policy also provides for Biofoundries, Biomanufacturing Hubs and Bio-AI Hubs to strengthen the infrastructure required to take innovations from the laboratory to pilot and commercial scale.

The government has subsequently expanded implementation of the policy to include support for pilot and pre-commercial scale biomanufacturing of viable bio-based products, including bioplastics.

BCML’s proposed R&D facility will complement its larger planned PLA manufacturing project at Kumbhi, where the company has announced an integrated commercial PLA facility with a proposed capacity of 80,000 tonnes per annum. The R&D facility is intended to support technology development before products are scaled up for commercial manufacturing.

3. Key Features

The ₹75-crore support will be used for establishing a pilot-scale R&D facility focused on PLA co-polymers and specialised PLA grades. The approximately 100-tonne-per-year facility is expected to support several stages of product development.

Its work will include developing new material formulations, testing their properties, producing pilot quantities and generating process know-how. The facility can also help validate products with potential users and improve technologies before they are transferred to larger-scale manufacturing.

This approach reflects the broader objective of BioE3: reducing the gap between laboratory research and industrial production by providing infrastructure for technology development, testing and scale-up.

4. Impact

The project could strengthen India’s domestic capabilities in biopolymer research and biomanufacturing. A dedicated pilot facility can allow researchers and industry to experiment with different PLA formulations and co-polymers without immediately moving to full commercial-scale production.

For BCML, the R&D facility will provide a platform for developing next-generation PLA products and building the technical knowledge needed for commercial manufacturing. It is also expected to support customer validation and technology scale-up.

At the wider industry level, government-backed infrastructure of this kind can help Indian companies develop indigenous technologies for bio-based materials. This is relevant as industries explore alternatives to conventional fossil-fuel-based materials and look for more sustainable manufacturing processes.

The project also fits within the government’s broader effort to develop a domestic biomanufacturing ecosystem. The PLA co-polymer R&D facility, under the government’s flagship BioE3 (Biotechnology for Economy, Environment & Employment) initiative, will aid India’s indigenous biomanufacturing capabilities.

5. Conclusion

The ₹75-crore grant to Balrampur Chini Mills represents a government-supported effort to move bio-based polymer technology from research towards industrial application. The proposed 100-tonne-per-year PLA co-polymer R&D facility at Kumbhi will focus on product development, pilot production, testing and process development.

The project also demonstrates how the BioE3 Policy is being applied to strengthen India’s biomanufacturing ecosystem. By supporting pilot-scale infrastructure and industry participation, the initiative aims to bridge the gap between scientific research and commercial manufacturing.

As India expands its focus on bio-based chemicals, biopolymers and sustainable manufacturing, projects such as this can contribute to the development of domestic technologies, skilled technical capabilities and new applications for bio-based materials. Its eventual contribution to the market will depend on successful technology development, commercial scale-up and adoption of the resulting PLA products.